- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00497419
Reperfusion Time in ST Segment Elevation Myocardial Infarction (STEMI)
August 19, 2008 updated by: University Hospital, Geneva
Evaluation of a Fast Track for Patients With STEMI
Reperfusion delay in STEMI has been shown to be excessive in our community.
In order to improve delay a fast track (direct transfer in catheterization laboratory) has been implemented.
The present study aims at evaluating the benefits of this procedure.
Study Overview
Detailed Description
Reperfusion delay in STEMI has been shown to be excessive in our community.
Admission in emergency room and waiting for transfer to catheterization laboratory seems to be the principal source of delay.
In order to improve delays a fast track (direct transfer in catheterization laboratory) has been implemented for patients being diagnosed with STEMI by emergency physician out of hospital.
The present study aims at evaluating the benefits of this procedure.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Geneva, Switzerland, 1211
- Geneva University Hospital, Emergency Service
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of STEMI
Exclusion Criteria:
- On site resuscitated patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Door to balloon time
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Olivier Grosgurin, MD, University Hospital, Geneva
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
October 1, 2007
Study Completion (Actual)
October 1, 2007
Study Registration Dates
First Submitted
July 5, 2007
First Submitted That Met QC Criteria
July 5, 2007
First Posted (Estimate)
July 6, 2007
Study Record Updates
Last Update Posted (Estimate)
August 20, 2008
Last Update Submitted That Met QC Criteria
August 19, 2008
Last Verified
August 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06199
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.